San Diego-based Genalyte announced Thursday its SARS-CoV-2 Multi-Antigen Serology Panel, which tests for antibodies the body produces in response to the novel coronavirus, is available to the public in partnership with San Diego Blood Bank.
A reliable antibody test represents a crucial step in helping to develop an understanding of the virus, including how long antibodies stay in the body, and if people with antibodies are less susceptible to reinfection.